EUVIMEDEUVIMED entdecken
Crossref

G Protein-Coupled estrogen receptor negatively regulates cell rigidity and osteogenic differentiation in bone marrow-derived mesenchymal stem cells

Ya-Shuan Chou, Shu-Chun Chuang, Che Wei Wu, Yun-Ya Tsao, Chung-Hwan Chen, Mei-Ling Ho, Je-Ken Chang

Biochemical Pharmacology · 2026-09 · 251 · 118079

DOI: 10.1016/j.bcp.2026.118079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-09. Verfasst von Ya-Shuan Chou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medic…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Receptors, G-Protein-Coupled, Osteogenesis, Cell Differentiation. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Health Research Institutes, Ministry of Science and Technology, Taiwan, Kaohsiung Municipal Ta-Tung Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estrogen plays pivotal roles in regulating bone formation and mineralization via estrogen receptors. Although the expression of G protein-coupled estrogen receptor-1 (GPER-1) is widespread in eukaryotic cells like bone marrow-derived mesenchymal stem cells (BMSCs), the precise mechanism by which this membrane receptor dictates BMSC differentiation has not been thoroughly established. In this study, we investigated whether GPER-1 regulates BMSC osteogenesis by modulating cytoskeletal dynamics and cellular rigidity via the Ras homolog family member A (RhoA) signaling pathway. Murine BMSCs were treated with the GPER-1 agonist G1, antagonist G15, or GPER-1-targeted siRNA, and changes in cell morphology, F-actin organization, focal adhesion, and stiffness were assessed using confocal and atomic force microscopy. RhoA activity was measured using pull-down assays, and osteogenic differentiation was evaluated based on Alizarin Red S (ARS) staining and osteogenic gene expression. Treatment with G1 significantly suppressed RhoA activation in BMSCs, reduced the thickness of actin filaments and number of focal adhesions, and diminished cellular tension. Importantly, GPER-1 activation reduced mineralization and osteogenic gene expression. Furthermore, treatment with G15 attenuated the inhibitory effects of G1. These findings indicate that GPER-1 negatively regulates the osteogenic differentiation of murine BMSCs by inhibiting RhoA-mediated cytoskeletal remodeling, associated with the RhoA/actin/cell rigidity axis. Collectively, our findings in this study reveal a previously unrecognized regulatory role of GPER-1 in bone biology and identify this receptor as a potential therapeutic target for modulating stem cell differentiation during skeletal regeneration and osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsReceptors, G-Protein-CoupledOsteogenesisCell DifferentiationReceptors, EstrogenBone Marrow CellsAnimalsMicerhoA GTP-Binding ProteinCells, CulturedMice, Inbred C57BLQuinolines

Stichwörter der Autor:innen

G protein-coupled estrogen receptor-1Murine BMSCOsteogenesis

Substanzen

Receptors, G-Protein-CoupledGPER1 protein, mouseReceptors, EstrogenrhoA GTP-Binding ProteinQuinolinesRhoA protein, mouse

Autor:innen und Institutionen

  • Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Orthopedic Surgery, Un…
  • Department of Food Science, Yuanpei University of Medical Technology, Hsinchu City, Taiwan; Departments of Food Science, National Chiayi University, Chiayi, Taiwan.
  • Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Orthopaedics, Kaohsiun…
  • Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Medicine, Coll…
  • Orthopaedic Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Orthopedics, Kaohsiung…

Förderung

  • National Health Research Institutes
  • Ministry of Science and Technology, Taiwan
  • Kaohsiung Municipal Ta-Tung Hospital
  • Kaohsiung Medical University
  • National Science and Technology Council
  • Kaohsiung Medical University Chung-Ho Memorial Hospital
  • National Cheng Kung University

Zitieren

APA

Chou, Y. S., Chuang, S. C., Wu, C. W., Tsao, Y. Y., Chen, C. H., Ho, M. L., & Chang, J. K. (2026). G Protein-Coupled estrogen receptor negatively regulates cell rigidity and osteogenic differentiation in bone marrow-derived mesenchymal stem cells. Biochemical Pharmacology, 251, 118079. https://doi.org/10.1016/j.bcp.2026.118079

Vancouver

Chou YS, Chuang SC, Wu CW, Tsao YY, Chen CH, Ho ML, et al. G Protein-Coupled estrogen receptor negatively regulates cell rigidity and osteogenic differentiation in bone marrow-derived mesenchymal stem cells. Biochemical Pharmacology. 2026;251:118079. doi:10.1016/j.bcp.2026.118079

BibTeX
@article{Chou2026,
  author = {Chou, Ya-Shuan and Chuang, Shu-Chun and Wu, Che Wei and Tsao, Yun-Ya and Chen, Chung-Hwan and Ho, Mei-Ling and Chang, Je-Ken},
  title = {G Protein-Coupled estrogen receptor negatively regulates cell rigidity and osteogenic differentiation in bone marrow-derived mesenchymal stem cells},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {251},
  pages = {118079},
  doi = {10.1016/j.bcp.2026.118079}
}
Kostenlos starten →